Cerebral Palsy Research Program Authorization Act of 2025
Summary
What This Bill Does
The Cerebral Palsy Research Program Authorization Act creates a new Public Health Service Act section for cerebral palsy research. HHS, acting through the CDC Director and in consultation with other federal agencies and partners, must carry out research directly or through grants and contracts. The program covers promising diagnosis and treatment avenues, factors that may reduce prevalence, health care and societal costs, public health surveillance, and education or training for health professionals and the public on causes, prevalence, diagnosis, treatment, and lifelong effects. HHS may provide technical assistance to public and nonprofit private entities, must evaluate program activities including demographic effects, and receives an authorization of $5 million for each of fiscal years 2026 through 2031.
Who Benefits and How
People with cerebral palsy benefit because CDC research can focus on diagnosis, treatment, prevalence, costs, and lifelong effects. Cerebral palsy researchers benefit from grants, contracts, surveillance activity, and technical assistance authority. Health professionals benefit from education and training resources on diagnosing, treating, and explaining cerebral palsy. Public health surveillance programs benefit from dedicated authority to collect and evaluate data on cerebral palsy.
Who Bears the Burden and How
CDC research staff must design and administer the research, surveillance, education, technical assistance, and evaluation program. HHS grant officers must manage grants or contracts and evaluate program effects across demographic populations. Federal taxpayers fund the $5 million annual authorization for fiscal years 2026 through 2031. Public and nonprofit grantees must meet federal research, reporting, and evaluation expectations.
Key Provisions
- Creates a Public Health Service Act cerebral palsy research program.
- Authorizes research on diagnosis, treatment, prevalence mitigation, health care costs, and societal costs.
- Directs public health surveillance, education, training, technical assistance, and program evaluation.
- Authorizes $5 million annually for fiscal years 2026 through 2031.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Authorizes CDC, through HHS, to run a cerebral palsy research, surveillance, education, technical assistance, and evaluation program with $5 million authorized annually for fiscal years 2026 through 2031.
Key Policy Areas
Health Research, Disability, Public Health
Primary Purpose
Authorizes CDC, through HHS, to run a cerebral palsy research, surveillance, education, technical assistance, and evaluation program with $5 million authorized annually for fiscal years 2026 through 2031.
Policy Domains
Resolution provisions
Identified Gains
- People with cerebral palsy
- Cerebral palsy researchers
- Health professionals
- Public health surveillance programs
Identified Costs
- CDC research staff
- HHS grant officers
- Federal taxpayers
- Public nonprofit grantees
Sponsors
Legislative Progress
In CommitteeMr. Cohen (for himself, Mr. Fitzpatrick, Mr. Cleaver, and Ms. …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Health professionals, People with cerebral palsy
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology